Markets.com Logo
markets.com

SYNE

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    --
  • Previous Close
    --
  • 52 Week Change
    --
  • Day Range
    --
  • 52 Week High/Low
    --
  • Dividend Per Share
    --
  • Market cap
    --
  • EPS
    --
  • Beta
    --
  • Volume
    --

About

SYNE.US represents Concert Pharmaceuticals Holdings, Inc., a biopharmaceutical company in the late clinical stage. Concert Pharmaceuticals focuses on developing novel medicines through deuterated chemical modifications. The company's primary drug candidate is deuruxolitinib (CTP-543), which is being developed for the treatment of alopecia areata, an autoimmune disorder that results in hair loss. Concert Pharmaceuticals is publicly traded on the NASDAQ stock exchange.
markets.com
Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Julian Parker|--
AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

Daniel Carter|--
AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

Julian Parker|--
British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

Julian Parker|--
Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Daniel Carter|--

The energy sector remains a hot topic & precious metals

Darius Anucauskas|--
Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Julian Parker|--

Factors

Syneos Health's stock price, SYNE.US, is influenced by various factors.

Company Performance: Syneos Health's financial results, including revenue growth, profitability, and earnings per share, directly impact investor confidence and stock valuation.

Industry Trends: Developments in the biopharmaceutical and healthcare industries, such as increased R&D spending or regulatory changes, affect demand for Syneos Health's services.

Market Conditions: Overall market sentiment, economic indicators, and interest rates influence investor behavior and the attractiveness of SYNE.US relative to other investment options.

Competition: The competitive landscape, including the presence of other contract research organizations (CROs), impacts Syneos Health's market share and pricing power.

Acquisitions and Mergers: Corporate actions like mergers, acquisitions, or divestitures can alter Syneos Health's business structure and future prospects, influencing stock price.

Regulatory Environment: Changes in healthcare regulations or drug approval processes affect the demand for clinical trials and related services provided by Syneos Health.

Clinical Trial Success: The success rate and outcomes of clinical trials managed by Syneos Health can impact the company's reputation and future business opportunities.

Investor Sentiment: News articles, analyst ratings, and investor perception of Syneos Health's management and strategy can drive buying or selling pressure on the stock.

People Also Watch

Latest news

Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

Julian Parker|--
McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

Julian Parker|--
Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

Julian Parker|--

Latest Education Articles

Risk Management 101

Risk Management 101

Julian Parker|--
Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

Julian Parker|--
Gold Scalping Strategy: How Scalping XAU/USD Works

Gold Scalping Strategy: How Scalping XAU/USD Works

Julian Parker|--
Recommended Topics
markets.com